Construction of the Biologics Manufacturing Centre was completed in June 2021, but there are still some remaining steps before Health Canada can license the facility, enabling the production of vaccines for human use.
What are those steps? What progress has been made? What exactly does it take to make a facility like the Biologics Manufacturing Centre compliant with good manufacturing practices (GMP) and therefore eligible for a drug establishment licence?
To help answer these questions, we're putting the spotlight on what and who is inside the Biologics Manufacturing Centre, and outlining some of literally thousands of steps—some small, some massive—required to make a new GMP‑compliant facility ready for licensing and for making a new vaccine—at the same time. Check back often to learn more.